Stanisław Surma

1.9k total citations · 1 hit paper
92 papers, 960 citations indexed

About

Stanisław Surma is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stanisław Surma has authored 92 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 21 papers in Cardiology and Cardiovascular Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stanisław Surma's work include Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (9 papers). Stanisław Surma is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (9 papers). Stanisław Surma collaborates with scholars based in Poland, United States and United Kingdom. Stanisław Surma's co-authors include Maciej Banach, Monika Romańczyk, Amirhossein Sahebkar, Krzysztof J. Filipiak‬, Suzanne Oparil, Marcin Adamczak, Bożena Sosnowska, Peter E. Penson, Joanna Lewek and Magdalena Olszanecka‐Glinianowicz and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Stanisław Surma

80 papers receiving 948 citations

Hit Papers

The association between daily step count and all-cause an... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanisław Surma Poland 18 240 187 132 127 119 92 960
Hua Peng China 17 183 0.8× 259 1.4× 122 0.9× 199 1.6× 167 1.4× 47 1.1k
Marko Kumrić Croatia 15 143 0.6× 128 0.7× 50 0.4× 107 0.8× 163 1.4× 89 851
Charles German United States 15 202 0.8× 324 1.7× 115 0.9× 161 1.3× 100 0.8× 51 869
Mahima Khatri Pakistan 17 200 0.8× 276 1.5× 54 0.4× 288 2.3× 150 1.3× 67 1.0k
Arun Kumar India 15 207 0.9× 202 1.1× 50 0.4× 56 0.4× 101 0.8× 128 836
Hyun Ah Park South Korea 22 181 0.8× 200 1.1× 299 2.3× 105 0.8× 148 1.2× 98 1.3k
Jing Bai China 13 125 0.5× 136 0.7× 122 0.9× 57 0.4× 78 0.7× 44 725
Hui Jin China 21 155 0.6× 64 0.3× 118 0.9× 128 1.0× 207 1.7× 73 1.1k
Jan Hoong Ho United Kingdom 16 307 1.3× 195 1.0× 86 0.7× 219 1.7× 79 0.7× 46 846
Zohaib Iqbal United Kingdom 13 163 0.7× 105 0.6× 80 0.6× 183 1.4× 87 0.7× 29 858

Countries citing papers authored by Stanisław Surma

Since Specialization
Citations

This map shows the geographic impact of Stanisław Surma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanisław Surma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanisław Surma more than expected).

Fields of papers citing papers by Stanisław Surma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanisław Surma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanisław Surma. The network helps show where Stanisław Surma may publish in the future.

Co-authorship network of co-authors of Stanisław Surma

This figure shows the co-authorship network connecting the top 25 collaborators of Stanisław Surma. A scholar is included among the top collaborators of Stanisław Surma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanisław Surma. Stanisław Surma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banach, Maciej, Stanisław Surma, Agata Bielecka‐Dąbrowa, et al.. (2025). Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.. Archives of Medical Science. 21(1). 1–15. 2 indexed citations
3.
Surma, Stanisław, Michał Czapla, Izabella Uchmanowicz, et al.. (2025). Prolonged Hospital Stay in Hypertensive Patients: Retrospective Analysis of Risk Factors and Interactions. Nursing Reports. 15(3). 110–110. 1 indexed citations
4.
Gluba-Brzózka, Anna, Robert Olszewski, Beata Franczyk, et al.. (2025). High-density lipoproteins. Part 2. Impact of disease states on functionality. American Journal of Preventive Cardiology. 23. 101073–101073. 2 indexed citations
5.
Surma, Stanisław & Gregory Y.H. Lip. (2025). Periodontitis and atrial fibrillation. European Journal of Preventive Cardiology.
6.
Lee, Christopher S., Marta Wleklik, Michał Czapla, et al.. (2025). Trends in cardiovascular risk factors in poland: results from the comprehensive cardiovascular risk prevention program. BMC Public Health. 25(1). 2962–2962.
7.
Franczyk, Beata, Ewelina Młynarska, Magdalena Rysz-Górzyńska, et al.. (2025). High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels. American Journal of Preventive Cardiology. 23. 101068–101068.
8.
Banach, Maciej, Stanisław Surma, Grzegorz Dzida, et al.. (2024). The Prevention Opportunities of Retinopathy in Diabetic Patients - the Position Paper endorsed by the Polish Lipid Association.. Archives of Medical Science. 20(6). 1754–1769.
9.
Surma, Stanisław & Suzanne Oparil. (2024). Zilebesiran — the first siRNA-based drug in hypertensiology: why is it needed, and will it change the treatment approach of hypertension?. SHILAP Revista de lepidopterología. 28(0). 1–11. 3 indexed citations
10.
Surma, Stanisław & Grzegorz Gajos. (2024). Alcohol, health loss and mortality: can wine really save the good name of moderate alcohol consumption?. Polskie Archiwum Medycyny Wewnętrznej. 134(4). 2 indexed citations
11.
Surma, Stanisław, et al.. (2023). Eliminating atherosclerotic cardiovascular disease residual risk. European Heart Journal. 44(45). 4731–4733. 18 indexed citations
13.
Banach, Maciej & Stanisław Surma. (2023). A Look to the Past - What Has Had the Biggest Impact on Lipids in the Last Four Decades? A Personal Perspective. Archives of Medical Science. 19(3). 559–564. 12 indexed citations
14.
Surma, Stanisław, et al.. (2023). Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action. Journal of Cardiovascular Development and Disease. 10(7). 268–268. 9 indexed citations
15.
Banach, Maciej, Stanisław Surma, Agnieszka Kapłon‐Cieślicka, et al.. (2023). Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association. Archives of Medical Science. 20(1). 28–42. 6 indexed citations
16.
Surma, Stanisław, et al.. (2023). Effect of Renal Denervation on the Plasma Adiponectin Concentration in Patients with Resistant Hypertension. Journal of Clinical Medicine. 12(6). 2114–2114. 3 indexed citations
17.
Surma, Stanisław, Monika Romańczyk, Michał Zembala, & Krzysztof J. Filipiak‬. (2023). Coffee and lipid profile: from theory to everyday practice. Folia Cardiologica. 18(1). 24–30. 1 indexed citations
18.
Surma, Stanisław & Gregory Y.H. Lip. (2023). Alcohol and Atrial Fibrillation. Reviews in Cardiovascular Medicine. 24(3). 73–73. 5 indexed citations
19.
Banach, Maciej, Stanisław Surma, Željko Reiner, et al.. (2022). Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022). Cardiovascular Diabetology. 21(1). 263–263. 56 indexed citations
20.
Surma, Stanisław & Maciej Banach. (2021). Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies. International Journal of Molecular Sciences. 23(1). 193–193. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026